OBSOLETE: Congenital absence of upper arm and forearm with hand present, bilateral Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

1Open funds

Regulatory Watchboard

1 event

Nov 1984

Trexan: FDA approved

For blockade of the pharmacological effects of exogenously administered opioids as an adjunct to the maintenance of the opioid-free state in detoxified formerly opioid-dependent individuals.

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance1

Trexan

DuPont Pharmaceuticals

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Trexan

(Naltrexone HCl)Orphan drug

DuPont Pharmaceuticals

Approved Nov 1984

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for OBSOLETE: Congenital absence of upper arm and forearm with hand present, bilateral.
Search all trials →

Search clinical trials for OBSOLETE: Congenital absence of upper arm and forearm with hand present, bilateral →